Calculating prostate cancer volume preoperatively: The d'Amico equation and some other observations

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 1998-2003

  Chan, Lung Wai ^a   Stamey, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

ARTICLE; CANCER GRADING; CANCER STAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

EID: 0344359729     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63225-7     Document Type: Article

References (16)

1. McNeal, J. E., Bostwick, D. G., Freiha, F. S., Kindrachuk, R. A., Redwine, E. A. and Stamey, T. A.: Patterns of progression in prostate cancer. Lancet, 1: 60, 1986.
2. Stamey, T. A., McNeal, J. E., Freiha, F. S. and Redwine, E.: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J. Urol., 139: 1235, 1988.
3. McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer, 66: 1225, 1990.
4. Stamey, T. A.: Making the most out of six systematic sextant biopsies. Urology, 45: 2, 1995.
5. Noldus, J. and Stamey, T. A.: Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients. J. Urol., 155: 232, 1996.
6. Cost, G. A. and Stamey, T. A.: Clinical detection of large volume prostate cancer. J. Urol., part 2, 155: 550A, abstract 957, 1996.
7. D'Amico, A. V. and Propert, K. J.: Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy. Int. J. Rad. Oncol. Biol. Phys., 35: 273, 1996.
8. D'Amico, A. V., Chang, H., Holoupka, E., Renshaw, A., Desjarden, A., Chen, M., Loughlin, K. and Richie, J.: Calculated prostate cancer volume: the optimal predictor of the actual cancer volume. Urology, 49: 385, 1997.
9. D'Amico, A. V., Whittington, R., Schultz, D. Malkowicz, S. B., Tomaszewski, J. E. and Wein, A.: Outcome based staging for clinically localized adenocarcinoma of the prostate. J. Urol., 158: 1422, 1997.
10. Marks, L. S., Treiger, B., Dorey, F. J., Fu, Y. S. and deKernion, J. B.: Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands. Urology, 44: 486, 1994.
11. Lepor, H., Wang, B. and Shapiro, E.: Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology, 44: 199, 1994.
12. Aihara, M., Lebovitz, R. M., Wheeler, T. M., Kinner, B. M, Ohori, M. and Scardino, P. T.: Prostate specific antigen and Gleason grade: an immunohistochemical study of prostate cancer. J. Urol., 151: 1558, 1994.
13. Stamey, T. A., McNeal, J. E., Yemoto, C. M., Sigal, B. M. and Johnstone, I. M.: Gleason sums of 7 lose valuable prognostic information in comparison to estimates of % grade 4 and 5 cancer. J. Urol., part 2, 157: 204A, abstract 794, 1997.
14. McNeal, J. E. and Noldus, J.: Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. Urology, 48: 751, 1996.
15. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
16. Kabalin, J. N., McNeal, J. E., Johnstone, I. M. and Stamey, T. A.: Serum prostate specific antigen and the biologic progression of prostate cancer. Urology, 46: 65, 1995.